Related by context. Frequent words. (Click for all words.) 76 Safe GRAS 76 Generally Recognized 73 GRAS status 62 Application BLA 60 tagatose 59 supplemental Biologics License Application 59 Release Tablets 59 erythritol 59 plant sterol 58 LIALDA 58 Oral Solution 58 injection USP 58 Orphan Drug status 58 BioSilicon TM 58 Hydrochloride 57 liprotamase 57 Injection USP 56 Application MAA 56 Drug Submission 56 Ascorbic Acid 56 Act PDUFA date 56 REVLIMID lenalidomide 56 Marketing Authorisation 56 Surgical Adhesive 56 Orphan Drug designation 56 submitted Biologics License 55 Biologics License Application 55 Lipid Nutrition 54 VALSTAR 54 Drug Application 54 Swissmedic 54 Argatroban 54 Delayed Release 54 lanthanum carbonate 54 liposomal formulation 54 Investigational Device Exemption 54 Inulin 54 IND Investigational New 54 Panzem R 54 Extended Release 54 Alitretinoin 53 Bioactive 53 microencapsulated 53 Ampligen ® 53 NOXAFIL 53 Australian Therapeutic Goods 53 Levofloxacin 53 USFDA approval 53 Recombinant Human 53 FDA Accepts 53 Omacor 53 Pennsaid R 53 PureVia 53 application sNDA 53 CryoSeal FS System 53 Beta Carotene 53 Injectable Suspension paclitaxel 53 rebiana 53 Combidex 53 Market Approval PMA 53 FIRAZYR 53 Galapagos NV Euronext GLPG 53 Ondansetron 53 Amyvid 53 GMP certification 53 dry powder inhaler 53 Amino Acid 52 OsmoPrep 52 FDA Complete Response 52 Drug Administration USFDA 52 BioGlue R 52 OPANA ER 52 Investigational Device Exemption IDE 52 DC Bead 52 Marketing Authorization 52 Priority Review 52 Mutual Recognition Procedure 52 Rebif ® 52 Privigen 52 Captisol 52 FDA approvable letter 52 Vilazodone 52 Complete Response 52 QNEXA 52 sodium phosphate 52 pediatric exclusivity 52 Phase III Clinical Trial 52 FDA Orphan Drug 52 Drug Application ANDA 52 sBLA 52 gets USFDA nod 52 life'sDHA TM 52 Single Dose 52 Biologics License Application BLA 52 Ampligen r 52 #mg #mg [002] 52 Pivotal Phase III 52 oxybutynin 52 Extended Release Tablets 51 Nasal Spray 51 Oxaliplatin